UB Paderborn / Katalog / Suche / in CDI

An international study to increase concordance in Ki67 scoring

Modern pathology, 2015-06, Vol.28 (6), p.778-786

2015

Volltextzugriff (PDF)

DREAM On, DREAM Off: A Review of the Estrogen Paradox in Luminal A Breast Cancers

Biomedicines, 2024-06, Vol.12 (6), p.1300

2024

Volltextzugriff (PDF)

Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells

Journal of biomedical materials research. Part A, 2016-12, Vol.104 (12), p.3031-3044

2016

Volltextzugriff (PDF)

An International Ki67 Reproducibility Study

JNCI : Journal of the National Cancer Institute, 2013-12, Vol.105 (24), p.1897-1906

2013

Volltextzugriff (PDF)

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

JNCI : Journal of the National Cancer Institute, 2011-11, Vol.103 (22), p.1656-1664

2011

Volltextzugriff (PDF)

DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative Trial

Heliyon, 2022-01, Vol.8 (1), p.e08666-e08666, Article e08666

2022

Volltextzugriff (PDF)

Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion

Molecular cancer, 2011-07, Vol.10 (1), p.93-93, Article 93

2011

Volltextzugriff (PDF)

MUC1 Initiates Src-CrkL-Rac1/Cdc42–Mediated Actin Cytoskeletal Protrusive Motility after Ligating Intercellular Adhesion Molecule-1

Molecular cancer research, 2008-04, Vol.6 (4), p.555-567

2008

Volltextzugriff (PDF)

MUC1 Initiates a Calcium Signal after Ligation by Intercellular Adhesion Molecule-1

The Journal of biological chemistry, 2004-07, Vol.279 (28), p.29386-29390

2004

Volltextzugriff (PDF)

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

The lancet oncology, 2013, Vol.14 (1), p.72-80

2013

Volltextzugriff (PDF)

Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines

Frontiers in bioengineering and biotechnology, 2015-01, Vol.3, p.14-14

2015

Volltextzugriff (PDF)

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

Modern pathology, 2022-10, Vol.35 (10), p.1362-1369

2022

Volltextzugriff (PDF)

Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells

Acta biomaterialia, 2018-01, Vol.66, p.294-309

2018

Volltextzugriff (PDF)

DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer

Breast cancer research and treatment, 2011-05, Vol.127 (1), p.53-63

2011

Volltextzugriff (PDF)

Single and Combinational siRNA Therapy of Cancer Cells: Probing Changes in Targeted and Nontargeted Mediators after siRNA Treatment

Molecular pharmaceutics, 2016-12, Vol.13 (12), p.4116-4128

2016

Volltextzugriff (PDF)

Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study

Cancer research (Chicago, Ill.), 2020, Vol.80 (4_Supplement), p.P5-P5-02-01

2020

Volltextzugriff (PDF)

The importance of MUC1 cellular localization in patients with breast carcinoma: An immunohistologic study of 71 patients and review of the literature

Cancer, 2001-06, Vol.91 (11), p.1973-1982

2001

Volltextzugriff (PDF)

MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1

Clinical & experimental metastasis, 2005-11, Vol.22 (6), p.475-483

2005

Volltextzugriff (PDF)

The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer

Cancer research (Chicago, Ill.), 1996-09, Vol.56 (18), p.4244-4249

1996

Volltextzugriff (PDF)

MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats

Cancer research (Chicago, Ill.), 1998-12, Vol.58 (23), p.5577-5581

1998

Volltextzugriff (PDF)

Primary breast lymphoma: An immunohistologic study of 20 new cases

Cancer, 1990-12, Vol.66 (12), p.2602-2611

1990

Volltextzugriff (PDF)

Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells: siRNA DELIVERY IN TRIPLE-NEGATIVE BREAST CANCER AND NONMALIGNANT CELLS

Journal of biomedical materials research. Part A, 2016-12, Vol.104 (12), p.3031-3044

2016

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

An international study to increase concordance in Ki67 scoring

DREAM On, DREAM Off: A Review of the Estrogen Paradox in Luminal A Breast Cancers

Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells

An International Ki67 Reproducibility Study

Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group

DREAM, a possible answer to the estrogen paradox of the Women's Health Initiative Trial

Non-cysteine linked MUC1 cytoplasmic dimers are required for Src recruitment and ICAM-1 binding induced cell invasion

MUC1 Initiates Src-CrkL-Rac1/Cdc42–Mediated Actin Cytoskeletal Protrusive Motility after Ligating Intercellular Adhesion Molecule-1

An international multicenter study to evaluate reproducibility of automated scoring for assessment of Ki67 in breast cancer

Analytical validation of a standardised scoring protocol for Ki67 immunohistochemistry on breast cancer excision whole sections: an international multicentre collaboration

MUC1 Initiates a Calcium Signal after Ligation by Intercellular Adhesion Molecule-1

Adjuvant docetaxel, doxorubicin, and cyclophosphamide in node-positive breast cancer: 10-year follow-up of the phase 3 randomised BCIRG 001 trial

Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines

Systematically higher Ki67 scores on core biopsy samples compared to corresponding resection specimen in breast cancer: a multi-operator and multi-institutional study

Combinational siRNA delivery using hyaluronic acid modified amphiphilic polyplexes against cell cycle and phosphatase proteins to inhibit growth and migration of triple-negative breast cancer cells

DEAD box 1: a novel and independent prognostic marker for early recurrence in breast cancer

Single and Combinational siRNA Therapy of Cancer Cells: Probing Changes in Targeted and Nontargeted Mediators after siRNA Treatment

Analytical validation of a standardized scoring protocol for Ki67: phase 3 of an international multicenter collaboration

Abstract P5-02-01: Analytical validation and prognostic potential of an automated digital scoring protocol for Ki67: An International Ki67 Working Group study

The importance of MUC1 cellular localization in patients with breast carcinoma: An immunohistologic study of 71 patients and review of the literature

MUC1 mediates transendothelial migration in vitro by ligating endothelial cell ICAM-1

The breast mucin MUC1 as a novel adhesion ligand for endothelial intercellular adhesion molecule 1 in breast cancer

MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats

Primary breast lymphoma: An immunohistologic study of 20 new cases

Multiple siRNA delivery against cell cycle and anti-apoptosis proteins using lipid-substituted polyethylenimine in triple-negative breast cancer and nonmalignant cells: siRNA DELIVERY IN TRIPLE-NEGATIVE BREAST CANCER AND NONMALIGNANT CELLS

Suchergebnisse filtern